Attached files

file filename
EX-10.6 - EX-10.6 - BIODESIX INCd937421dex106.htm
EX-10.5 - EX-10.5 - BIODESIX INCd937421dex105.htm
EX-3.2 - EX-3.2 - BIODESIX INCd937421dex32.htm
S-1/A - S-1/A - BIODESIX INCd937421ds1a.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Biodesix, Inc.:

We consent to the use of our report dated May 27, 2020, except for earnings per share and Note 1(aa), as to which the date is August 12, 2020 and Note 14, as to which the date is October 20, 2020, included herein and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

Denver, Colorado

October 23, 2020